Research and Development Product Pipeline
Allergan Pharmaceuticals has multiple projects under various stages of development. These include products in the cardiovascular, hospital, neuroscience, and pediatric areas. We develop both new chemical entities as well as already approved molecules for new indications or in improved dosage forms. Our research scientists have extensive experience in clinical development and work collaboratively with the FDA to obtain market approval. The company has already filed four New Drug Applications (NDAs), three of which have been approved and also has several additional products in late stage development. The projects currently in clinical development are shown below.